Research Paper Volume 16, Issue 1 pp 714—745
LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior
Figure 9. Prediction of LAMP3 expression-related drugs. (A) An advanced network diagram shows 14 cancer-related drugs that can modulate LAMP3 expression. (B) An upset diagram demonstrates drugs related to LAMP3 expression in CTD, cancer drugs and cgp2014. Relationship between LAMP3 expression and IC50 of (C) sunitinib (D) bicalutamide (E) cisplatin and (F) doxorubicin.